[On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000627:therapeutic use*; D000996:Antitussive Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001987:Bronchiectasis / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005100:Expectorants / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011009:Pneumoconiosis / Q000188:drug therapy; D011658:Pulmonary Fibrosis / Q000188:drug therapy; D014050:Toluene / Q000627:therapeutic use*
D000814:Aniline Compounds; D000996:Antitussive Agents; D005100:Expectorants; D014050:Toluene
Sul trattamento di alcune forme di affezioni bronchiali acute e croniche con l'N-cicloesil-N-metil-(2-amino-3,5-dibromobenzil)-ammonio cloruro.